Dominik Maurer

Actively personalized vaccination trial for newly diagnosed glioblastoma

Norbert Hilf, Sabrina Kuttruff-Coqui, Katrin Frenzel et al. · Nature · 2018 · 932 citations · Full text

Medicine, Biomedical Sciences, Oncology +12

Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival

Steffen Walter, Toni Weinschenk, Arnulf Stenzl et al. · Nature Medicine · 2012 · 784 citations

Medicine, Immunology, Oncology +17

IMA901, a multipeptide cancer vaccine, plus sunitinib versus sunitinib alone, as first-line therapy for advanced or metastatic renal cell carcinoma (IMPRINT): a multicentre, open-label, randomised, controlled, phase 3 trial

Brian I. Rini, Arnulf Stenzl, Romauld Zdrojowy et al. · The Lancet Oncology · 2016 · 216 citations

Medicine, Immunology, Oncology +14

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

Susanna Mandruzzato, Sven Brandau, Cedrik M. Britten et al. · Cancer Immunology Immunotherapy · 2016 · 199 citations · Full text

Medicine, Hematology, Oncology +15

Activated human T lymphocytes express MHC class I heavy chains not associated with beta 2-microglobulin.

E Schnabl, Hannes Stockinger, Otto Majdic et al. · The Journal of Experimental Medicine · 1990 · 136 citations · Full text

Life Sciences, Immunology, Molecular Biology +17